Ramesh Kumar is CEO & President at Onconova Therapeutics, Inc. (ONTX). They have made 4 open-market trades across 2 companies since 2013, most recently 2022-10-06.
CIK 0001580074
3 open-market purchases totalling $163K since 2013, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCGN | SELL · 10b5-1 | 2022-10-06 | 2022-10-07 | $1.83 | $8K | -4.7% | -10.0% | -24.1% |
| OCGN | SELL · 10b5-1 | 2022-07-18 | 2022-07-20 | $2.57 | $19K | -8.0% | -10.6% | -40.1% |
| OCGN | SELL · 10b5-1 | 2022-04-18 | 2022-04-20 | $2.83 | $21K | -14.0% | -18.0% | -0.4% |
| OCGN | SELL · 10b5-1 | 2022-01-18 | 2022-01-20 | $4.07 | $31K | +12.2% | +22.6% | -21.7% |
| OCGN | SELL | 2021-10-18 | 2021-10-20 | $8.13 | $122K | +59.2% | -12.1% | -54.4% |
| OCGN | SELL · 10b5-1 | 2021-07-19 | 2021-07-21 | $6.40 | $48K | -9.7% | -3.8% | +9.7% |
| OCGN | SELL · 10b5-1 | 2021-04-19 | 2021-04-21 | $5.33 | $40K | +133.7% | +29.1% | +10.6% |
| ONTX | BUY | 2017-04-26 | 2017-04-28 | $2.10 | $50K | -1.3% | -13.9% | -12.1% |
| ONTX | SELL · 10b5-1 | 2014-01-30 | 2014-02-03 | $15.05 | $903K | -26.3% | -3.2% | -3.2% |
| ONTX | BUY | 2013-11-15 | 2013-11-18 | $12.02 | $13K | -26.3% | -3.2% | -3.2% |
| ONTX | BUY | 2013-07-30 | 2013-08-01 | $15.00 | $100K | -26.3% | -3.2% | -3.2% |
| ONTX | SELL · 10b5-1 | 2013-02-07 | 2014-02-11 | $15.07 | $506K | -26.3% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.